- Home
- ABEO vs KNOP Comparison
ABEO vs KNOP Comparison
Compare ABEO & KNOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- KNOP
- Stock Information
- Founded
- ABEO N/A
- KNOP 2013
- Country
- ABEO United States
- KNOP United Kingdom
- Employees
- ABEO N/A
- KNOP N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- KNOP Marine Transportation
- Sector
- ABEO Health Care
- KNOP Consumer Discretionary
- Exchange
- ABEO Nasdaq
- KNOP Nasdaq
- Market Cap
- ABEO 237.4M
- KNOP 254.2M
- IPO Year
- ABEO 1980
- KNOP 2013
- Fundamental
- Price
- ABEO $4.92
- KNOP $6.34
- Analyst Decision
- ABEO Strong Buy
- KNOP
- Analyst Count
- ABEO 5
- KNOP 0
- Target Price
- ABEO $17.00
- KNOP N/A
- AVG Volume (30 Days)
- ABEO 834.1K
- KNOP 126.3K
- Earning Date
- ABEO 05-14-2025
- KNOP 05-21-2025
- Dividend Yield
- ABEO N/A
- KNOP 1.65%
- EPS Growth
- ABEO N/A
- KNOP N/A
- EPS
- ABEO N/A
- KNOP 0.18
- Revenue
- ABEO N/A
- KNOP $312,629,000.00
- Revenue This Year
- ABEO N/A
- KNOP $5.04
- Revenue Next Year
- ABEO $539.93
- KNOP $1.00
- P/E Ratio
- ABEO N/A
- KNOP $34.67
- Revenue Growth
- ABEO N/A
- KNOP 8.60
- 52 Week Low
- ABEO $3.05
- KNOP $4.94
- 52 Week High
- ABEO $8.45
- KNOP $9.11
- Technical
- Relative Strength Index (RSI)
- ABEO 51.29
- KNOP 50.44
- Support Level
- ABEO $3.93
- KNOP $6.19
- Resistance Level
- ABEO $5.02
- KNOP $6.49
- Average True Range (ATR)
- ABEO 0.41
- KNOP 0.39
- MACD
- ABEO 0.06
- KNOP -0.07
- Stochastic Oscillator
- ABEO 90.83
- KNOP 38.99
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About KNOP KNOT Offshore Partners LP Common Units representing Limited Partner Interests
KNOT Offshore Partners LP owns, operates, and shuttles tankers under long-term charters in the North Sea and Brazil. The company provides crude oil loading, transportation, and storage services under time charters and bareboat charters. The Partnership is formed for acquiring ownership interests in over four shuttle tankers owned by Knutsen NYK Offshore Tankers AS (KNOT). It operates through the shuttle tanker market segment.